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ABSTRACT
Systemic lupus erythematosus (SLE) is per se a disease characterized by suppressed immune re-
sponse and thus susceptibility to various opportunistic infections. We describe the case of a 21-year-
old woman who developed a rare zoonosis - hemotrophic mycoplasma infection in the initial stage 
of SLE, complicated with Nocardia asteroides pneumonia afterwards. Nocardia infection coincided 
with initiation of glucocorticoids and cyclophosphamide therapy for SLE. After the treatment she 
recovered completely. To our knowledge the only case of human hemoplasmosis (then referred to 
as eperythrozoonosis) in medical literature was the one described by a group of Croatian authors 
22 years ago. No cases of a hemotrophic mycoplasma infection in a SLE patient have been published 
up to now.
Keywords: SLE, zoonosis; hemotrophic mycoplasma (hemoplasma), eperythrozoon, Nocardia 
asteroides.
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Rare zoonosis (hemotrophic mycoplasma infection) in a 
newly diagnosed systemic lupus erythematosus patient 
followed by a Nocardia asteroides pneumonia
INTRODUCTION
The immune system in SLE patients is sup-
pressed per se because of the autoimmune nature 
of the disease. Predisposing factors include low-
ered complement levels, impaired cell-mediated 
response and abnormalities in mononuclear 
phagocyte functions.1-3 A long-term use of steroi-
dal and other immunosuppressive therapy makes 
the patients even more immunocompromised, 
so it is not unexpected that various opportunis-
tic organisms take advantage of the host and in-
fect the body.1-3 The list of potential pathogens is 
wide and includes numerous widespread Gram+ 
and Gram- bacteria, viruses, parasites, fungi and 
mycoplasma. The main causes of death of SLE 
patients from the onset to the later stages of the 
disease include cardiovascular and infectious 
complications equally.4 This should be taken into 
consideration in the treatment of SLE patients 
and antibiotic prophylaxis and immunization is-
sued to high-risk patients to lower the morbidity 
and mortality rate. 
CASE REPORT 
A 21-year-old woman worked as a hairdresser 
in a rural island environment and had everyday 
contact with sheep, pigs, poultry, cats and mos-
quitoes. She had a history of recurrent (nearly 
once a year) labial herpes and tonsillitis and 
often received penicillin-based antibiotics. Her 
medical history was unremarkable otherwise. 
She did not use tobacco, alcohol or illicit drugs. 
For about a year she complained about pain-
ful, swollen fingers and ankles, and morning 
stiffness which lasted approximately 1 to 2 
hours. 
New symptoms began with an upper 
respiratory tract infection and a high fever. 
Despite the treatment with phenoxymethyl-
penicillin, her condition worsened so she 
was hospitalized in a local hospital. Physi-
cal examination revealed cervical, axillary 
and inguinal lymphadenopathy (approx. 1x1 
cm in diameter), mild hepatosplenomegaly 
and a silent systolic cardiac murmur. Labo-
ratory findings revealed mild pancytopenia. 
Bone marrow aspiration cytology showed a 
hypoplasia of all three lines of hematopoi-
etic system. The fever persisted so she was 
transferred to the Infectious Diseases Unit 
with the diagnosis being fever of unknown 
origin (FUO) and pancytopenia for further 
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diagnostic procedures and treatment. Upon arrival blood 
was drawn and the diagnosis of pancytopenia was con-
firmed. Other routine laboratory findings and serology are 
also shown in Table 1. 
A chest X-ray suggested a possible minor pneumonia, so 
she was given cephalosporin antibiotics. Another chest X-
ray, performed after several days , showed bilateral vascular 
hili and a pronounced horizontal fissure to the right with 
no pneumonic infiltrates. All urine and blood cultures were 
negative. Serological tests for malaria, brucellosis, typhus, 
tularemia, toxoplasmosis and leishmaniasis were nega-
tive as well. Echosonography of the heart showed a mini-
mal pericardial effusion with normal ejection fraction and 
no morphological pathology of the heart muscle and the 
valves. During her stay she developed vasculitis-like rash on 
her lower extremities around ankles. A skin biopsy was per-
formed – perivascular lymphocytes and RBCs were found 
in the upper dermis and blood vessels were deformed with 
neutrophil deposits in the deeper dermis. A fine needle as-
piration cytology of the cervical and axillary lymph nodes was 
performed and round, ring shaped cocci, 1-1.5 µm in diameter 
were found. A similar finding was revealed in a peripheral 
blood smear, where the same cocci were found on the sur-
face of RBCs and free in the plasma (Figure 1). This finding 
perplexed the patient’s physicians. Because of the positive 
epidemiological history, veterinarians were consulted and 
they recognized the cocci as the hemotrophic mycoplasma, 
so finally they diagnosed hemoplasmosis, zoonosis uncom-
mon in humans. 
aroused the suspicion that the patient may have a systemic 
disease of the connective tissue, so she was admitted to the 
Rheumatology Unit for additional diagnostic procedures 
and treatment. According to the ACR classification, the pa-
tient had five criteria (serositis – minimal pleural and peri-
cardial effusions; renal disorder - proteinuria; hematological 
disorder - anemia, leucopenia, thrombocytopenia and im-
munological disorder - positive anti-double stranded DNA 
and antinuclear antibodies) for the diagnosis of systemic 
lupus erythematosus. Her complement C3 and C4 levels 
were low as well. Blood transfusions were administered. She 
received corticosteroids, first intravenously and afterwards 
orally (1 mg/kg/day). Within a few days, the patient’s tem-
perature fell and the complete blood count improved con-
siderably (Table 1). This was an indirect indicator that the 
pancytopenia was SLE induced. Methyl-prednisolone was 
slowly tapered to 0.5 mg/kg/day to avoid steroid side-
effects. Elevated blood pressure values, reduced diuresis 
Figure 1: Hemotrophic mycoplasma on the surface of the 
RBCs in the peripheral blood smear.
Pancytopenia, hepatosplenomegaly, peripheral lym-
phadenopathy and bone marrow hypoplasia were all signs 
of zoonosis. She was treated with tetracyclines for 18 days 
and there was a significant regression of lymphadenopathy, 
but her complete blood count and general condition did 
not get any better. Pancytopenia, intermittent fever, ma-
laise, body weight loss, perimaleolar oedema and a vasculitis 
skin changes persisted. Positive immunological blood tests 
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Table 1. Laboratory findings
laboratory findings Infectious rheumatology 
 Diseases Unit
 Unit 
RBC / x 109 /L 3.02 3.8
Hb / g/dL 8.2 10.9
MCV / fl 80 84
WBC / x 109 /L 1.7 13.5
Platelets / x 109 /L 62 185
ESR  84-94-130 13-27
CRP / mg/L 40 5
Creatinine /  Normal 130
µmol/L 
Creatinine  Normal 48
clearance
/ mL/min 
Aminotransferasis Normal Normal
Urine Proteins  Proteinuria/24h 
 +++ 2.4 g/L
Waaler Rose  1:256 Negative
Latex  1:320 Negative
ANA Positive Negative
anti-dsDNA Positive Negative
RBC – Red blood cells; Hb – Hemoglobin; MCV – Mean cor-
puscular volume; WBC – White blood cells; ESR - Erythrocyte 
sedimentation rate; CRP – C reactive protein; ANA – Antinu-
clear antibodies; anti-dsDNA – anti double stranded DNA 
antibodies. 
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and persistent hematuria were registered. A diuretic was 
added. In the meantime there was a relapse of hemoplas-
mosis, manifested as worsening of lymphadenopathy. The 
relapse of the zoonosis coincided with the introduction of 
systemic corticosteroids in the treatment of SLE. She re-
ceived additional tetracycline antibiotics. Her renal status 
worsened with proteinuria of 2.4 g/L, reduced creatinine 
clearance, severe perimaleolar oedema and hypertension. 
A renal biopsy was performed and mezangioproliferative 
lupus nephritis with segmental scleroses and membrano-
prolipherative changes and IgG and C3 complement frac-
tion deposits near a basal membrane were diagnosed (ac-
cording to the revised classification of the International 
Society of Nephrology and the Renal Pathology Society 
for lupus nephritis, these renal biopsy findings satisfy the 
criteria for class IV-S).5 The steroid level was once again 
elevated to 1 mg/kg/day combined with cyclophosphamide 
(2x50 mg/day) and her general condition improved grad-
ually. Within a few days she was feeling much better and 
laboratory findings improved as well. She was discharged 
with the advice of taking methyl-prednisolone 1 mg/kg/
day (a 10% dose reduction every 7 days until the main-
tenance dose reached 20 mg/day) and cyclophosphamide 
2x50 mg/day.
A month later she was hospitalized again because of 
cough and a high fever. Chest X-ray showed an infracla-
vicular cavern, 6 cm in diameter with a 1 cm thick wall 
(Figure 2). Bronchoscopy, bronchoalveolar lavage (BAL) 
and lung biopsy revealed the presence of Nocardia aster-
oides (Figure 3). She was given antibiotic trimethoprim-
sulfamethoxazole parenteraly at first and orally after-
wards, and within a few months there was a complete 
regression of the pathological findings on the chest X-ray. 
Complement levels (C3 and C4) remained lowered. There 
was no evidence of pancytopenia and polyclonal hyper-
gammaglobulinemia. Under the maintenance therapy 
SLE was in remission with no signs of hemoplasmosis. 
Unfortunately the patient stopped coming in for regular 
check-ups.
DISCUSSION
Hemotrophic mycoplasma, formerly known as Eperyth-
rozoon spp., is a small epicellular blood parasite without a 
cellular wall and is composed of circular, double-stranded 
DNA which encodes only the genes essential for life. The 
parasite is found in different species of vertebrates (sheep, 
goats, pigs, cattle, mice etc.). It attaches loosely to the surface 
of RBCs and sometimes destroys them but it can also be seen 
free in the plasma. Hemoplasmas are shown in the blood 
smear after Giemsa staining. It is most commonly found in 
pigs and can cause life-threatening anemia, jaundice and 
reproductive system problems.6,7 The disease is extremely 
rare in humans and manifests with fever, swollen lymph 
nodes, an enlarged spleen and liver, worsening anemia, leu-
copenia, thrombocytopenia and sometimes mild hepatitis 
and subclinical myocarditis. A group of Croatian authors 
described this rare condition in a single human patient 
22 years ago when the organism was known as Eperyth-
rozoon.8 To our knowledge that was the only time the 
human hemoplasmosis (eperythrozoonosis) was mentioned 
in medical literature. Cytological aspiration of an enlarged 
lymph node and peripheral blood smear can reveal typical 
rings or cocci organisms. Tetracyclines are the drugs of choice. 
Figure 2: Tomogram of the infraclavicular cavern (Nocardia 
asteroides) on the right.
Figure 3: Nocardia asteroides in the lung biopsy.
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Over time clinical improvement is seen, a rise in RBCs, WBC, 
platelets, reticulocyte count and the normalization of liver en-
zymes.
Hemoplasmas may act as a cofactor in the progression 
of retroviral, neoplasic and immune-mediated disease.7 It is 
possible that the unrecognized initial stage of systemic lupus 
erythematosus suppressed the immune system of the patient 
and made her more susceptible to hemoplasmosis. 
To our knowledge there has not been a single case of 
simultaneous hemotrophic mycoplasma infection and sys-
temic lupus erythematosus in medical literature up to now. 
Because this parasite affects animals, mostly pigs, physicians 
rarely take into consideration these microorganisms in the 
differential diagnosis of the lymphadenopathy in humans. 
The relapse of the hemoplasmosis in our patient coincides 
with the introduction of systemic glucocorticoids in the 
treatment of SLE. This can be explained by the steroidal anti-
inflammatory but also immunomodifying and a further im-
munosupressing effect on the immune molecular system. 
One of them is Nocardia asteroides, a Gram-positive vari-
ably acid-fast aerobic bacterium, widely distributed in the en-
vironment, also in airborne dust particles, so the most com-
mon site of involvement is the lung (81%), followed by the 
central nervous system (13%).9 Other sites of brain abscess, 
retinitis, thyroiditis and diaphragmatic infiltration.10 A good 
outcome of treatment with trimethoprim-sulfamethoxazole 
for pulmonary nocardiosis is showed in SLE patients.11
An aggressive approach to immunocompromised pa-
tients, quick diagnostic procedures and early empirical ther-
apy are essential principles of clinical management. 
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